Ledger.Open graph →
SEC Form D · filed April 4, 2023

Lennham Pharmaceuticals, Inc

Offering
$1.2M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CONCORD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Benjamin D. Enerson · Concord, MAExecBradford C. Sippy · Concord, MAExec · DirectorCorey D. Macgregor · Concord, MAExecThomas Kuegler · Gulf Breeze, FLExec · DirectorJames Boettcher · San Francisco, CAExecMatthew Mcgraw · San Francisco, CAExecPaul S. Bertrand · Drexel, MOExecKathleen A. Ruegsegger · Drexel, MOExecEric Varma · Greenwich, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗